Literature DB >> 2439503

Cellular catabolism of recombinant tissue-type plasminogen activator. Identification and characterization of a novel high affinity uptake system on rat hepatocytes.

C Bakhit, D Lewis, R Billings, B Malfroy.   

Abstract

The uptake, internalization, and intracellular degradation of 125I-labeled recombinant tissue-type plasminogen activator (rt-PA) by isolated rat hepatocytes was investigated. Incubation at 37 degrees C resulted in internalization of 125I-rt-PA, followed by the appearance of labeled trichloroacetic acid-soluble material in the incubation media due to degradation of rt-PA. Degradation of rt-PA was inhibited by the presence of NH4Cl (10 mM) or chloroquine (1 mM) (lysosomal tropic agents) in the incubation media. This suggests that rt-PA degradation occurs intracellularly, perhaps within the lysosomes. 125I-rt-PA was taken up by rat hepatocytes through a specific, high affinity mechanism with half-maximal uptake at 10 nM. Uptake of 125I-rt-PA was not inhibited by glycopeptides isolated from rt-PA nor by several other glycoproteins known to be cleared by identified hepatic receptors. These results suggest that the uptake of rt-PA by rat hepatocytes involves a receptor specific for t-PA and is not mediated by a carbohydrate-specific receptor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439503

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Localization of urokinase-type and tissue-type plasminogen activator mRNA during organogenesis in the mouse.

Authors:  Pierre -Alain Menoud; Sylvain Debrot; Jean Schowing
Journal:  Rouxs Arch Dev Biol       Date:  1989-11

Review 2.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

3.  Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.

Authors:  J Krause; W Seydel; G Heinzel; P Tanswell
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

4.  Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins.

Authors:  J Mordenti; S A Chen; J A Moore; B L Ferraiolo; J D Green
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

5.  Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.

Authors:  E Stang; N Roos; M Schlüter; T Berg; J Krause
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

6.  Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.

Authors:  M Otter; J Kuiper; R Bos; D C Rijken; T J van Berkel
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

7.  Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.

Authors:  G Bu; S Williams; D K Strickland; A L Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Clinical evaluation of tissue plasminogen activator (t-PA) levels in patients with liver diseases.

Authors:  K Okabe; I Kato; S Sato; T Kashiwabara; S Furuta; H Sato; K Tanikawa; R Kumashiro; M Kanayama
Journal:  Gastroenterol Jpn       Date:  1992-02

9.  alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.

Authors:  K A Hajjar; C M Reynolds
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions.

Authors:  J Kuiper; A Van't Hof; M Otter; E A Biessen; D C Rijken; T J van Berkel
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.